Do digestive enzymes help Ozempic® or Wegovy® sulfur burps and bloating?

Usually no. There is no clinical evidence that digestive enzymes reliably reduce sulfur burps, bloating, or fullness on GLP-1 medications. These symptoms are mainly caused by delayed gastric emptying (slow motility), with fermentation as a secondary factor. Because enzymes do not speed transit, results are inconsistent.

Why do GLP-1 medications cause gas, bloating, and sulfur burps?

GLP-1 medications slow gastric emptying, so food stays in the stomach and upper gut longer. This prolonged retention can increase microbial fermentation, which raises gas and sulfur-containing byproducts. That is why bloating and sulfur burps can happen even when digestion itself is not the main problem.

Why do digestive enzymes often fail on GLP-1 medications?

GLP-1 symptoms are usually caused by delayed gastric emptying (a mechanical "traffic jam"), not a primary enzyme deficiency. Enzymes may help break down food, but they do not open the stomach outlet or speed emptying. That is why pressure, heaviness, bloating, and sulfur burps often persist.

Why can porcine (pancreatic) digestive enzymes be a poor match for GLP-1 bloating and burps?

Many porcine or pancreatic enzymes are enteric-coated to survive stomach acid and activate in the small intestine. But GLP-1 symptoms often start while food is still retained in the stomach. If enzymes activate later downstream, they may not meaningfully reduce stomach-area bloating or frequent burping.

When might digestive enzymes be worth a short trial on GLP-1 medications?

A short trial may be reasonable only when symptoms are mainly gas or sulfur burps without significant "brick in the stomach" fullness, early satiety, or vomiting. In that pattern, fermentation may play a larger role and a trigger-matched enzyme may help. Stop after 3-5 meals if there is no benefit.

Which digestive enzymes are most logical to try for GLP-1-related gas or food triggers?

If you try enzymes, match them to the trigger: alpha-galactosidase for gas after beans or cruciferous vegetables, acid-stable protease for heavy meat meals, and microbial lipase for nausea after fatty meals. These do not treat delayed gastric emptying, so benefits are unpredictable and should be stopped if ineffective.

How do I choose an enzyme supplement label that is not misleading?

Ignore "high-potency" marketing, which often reflects capsule size, not effectiveness. Look for enzyme activity units (such as HUT, DU, or FIP), which are more meaningful than milligrams. For stomach-first symptom patterns, microbial or fungal enzymes may be a better theoretical match than enteric-coated porcine enzymes.

When should I stop enzymes or seek medical care for GLP-1 digestive symptoms?

Stop enzymes if there is no benefit after 3-5 meals, or if symptoms worsen. Avoid proteases if you have active gastritis or ulcer disease. Seek clinician evaluation for persistent vomiting, inability to tolerate liquids, or worsening abdominal pain to rule out severe delayed emptying or obstruction.

Digestive Enzymes for Ozempic® & Wegovy® Side Effects: Do They Help?

Joshua Silva, MD
6 days ago
5 min read

Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD

Do digestive enzymes help sulfur burps and bloating on GLP-1s?

No. There is no clinical evidence that digestive enzymes reliably reduce sulfur burps, bloating, or fullness caused by Ozempic or Wegovy. These symptoms are primarily driven by delayed gastric emptying (slowed motility), with fermentation as a secondary effect. Because enzymes do not correct slowed transit, symptom relief is inconsistent and unpredictable.¹–⁵

How GLP-1s cause gas and sulfur burps (The Mechanism)

GLP-1 medications slow gastric emptying, allowing food to remain longer in the stomach and upper gut. This prolonged retention increases downstream exposure to microbial fermentation, which can raise gas production and sulfur-containing byproducts. As a result, bloating and sulfur burps are biologically plausible even when digestion itself is not primarily impaired.¹–³,⁶,⁷

Does Simethicone Help with GLP-1 Bloating, Gas, or Sulfur Burps?

Simethicone (Gas-X®) may help mild gas or burping by breaking up gas bubbles, but there is no clinical evidence it reliably improves GLP-1–related bloating or sulfur burps because it does not treat delayed gastric emptying, the main cause of these symptoms.

2 Reasons Why Digestive Enzymes Fail on GLP-1s

1. The problem is motility, not primary digestion

GLP-1 medications cause delayed gastric emptying—a mechanical “traffic jam”—rather than a primary failure of food breakdown. Adding enzymes may increase molecular digestion but does not open the pyloric sphincter or accelerate stomach emptying, so pressure, fullness, and sulfur burps often persist.¹–³

2. Enzymes activate in the wrong location

Most pancreatic or porcine enzyme formulations are enteric-coated to survive stomach acid and activate in the small intestine. Because many GLP-1 symptoms occur while food is retained in the stomach, enzymes may pass the problem area without activating in time to relieve bloating or burping.¹–⁵

Can any digestive enzymes help with Ozempic side effects?

Important context: Digestive enzymes do not treat delayed gastric emptying. The table below reflects theoretical alignment with food triggers, not proven treatment of GLP-1 side effects.

Symptom Pattern	Enzyme Type	Why it might help (Mechanism)
Heavy fullness after meat	Acid-stable protease	Can remain active in acidic conditions and assist protein breakdown during prolonged gastric retention.¹³–¹⁵
Gas from vegetables or fiber	Alpha-galactosidase	Shown to reduce fermentation of oligosaccharides (e.g., beans, cruciferous vegetables) and gas-related symptoms in non-GLP-1 populations.⁶,⁷
Nausea after fatty meals	Microbial lipase	Targets fat hydrolysis; may help some individuals if fat digestion or bile timing is contributory, but does not alter gastric emptying.¹⁶

Label note: “High-potency” claims usually reflect capsule weight (mg), not enzyme activity. Activity units (e.g., HUT, DU, FIP) are more meaningful than milligrams.¹³–¹⁵

4 Signs Digestive Enzymes Won’t Help You

You have the “brick in stomach” sensation

This reflects physical volume retention from delayed emptying. Enzymes cannot meaningfully reduce gastric volume or pressure fast enough to relieve this feeling.¹–³
You have early satiety

Early fullness is a hormone-mediated effect of GLP-1 therapy, not a digestive failure. Enzymes cannot override central satiety signaling.
You are vomiting

Vomiting suggests significant gastric intolerance or obstruction and requires medical evaluation or antiemetic therapy—not supplements.¹–²
You see no benefit after 3–5 meals

Enzymes act immediately on contact with food. If symptoms do not improve after several consecutive meals, they are mechanistically unlikely to help.⁴,⁵

H2: When digestive enzymes may be worth a short trial on GLP-1s

Digestive enzymes may be worth a brief, cautious trial only if gas or sulfur burps occur without significant fullness, early satiety, or vomiting. In these cases, fermentation may play a larger secondary role, and trigger-matched enzymes may provide limited relief—though benefit remains unpredictable and not evidence-proven.¹–⁷

Consider a short trial only if:

Symptoms are mainly gas/sulfur burps, not “brick” fullness
Symptoms follow specific trigger foods (beans/crucifers)
You are not vomiting and can tolerate fluids
You stop after 3–5 meals if there’s no benefit⁴,⁵

Why digestive enzymes are heavily marketed to people on GLP-1 medications

Digestive enzymes are frequently marketed to GLP-1 users because bloating, gas, and sulfur burps are common and frustrating symptoms, and dietary supplements can be sold without proving clinical efficacy. Marketing claims often extrapolate from non-GLP-1 digestive conditions and exceed available clinical evidence.¹–⁵

Clinical context:Many enzyme products are promoted as “high-potency” or “GLP-1 supportive” despite lacking GLP-1–specific clinical trials. While some enzymes reduce gas in non-GLP-1 populations, delayed gastric emptying—not enzyme deficiency—is the dominant driver of GLP-1 digestive side effects, limiting predictable benefit.¹–⁵

Safety warnings: digestive enzymes on GLP-1s

Digestive enzymes are dietary supplements, not FDA-approved treatments for gastroparesis or GLP-1 intolerance.

Ulcer or gastritis risk: Proteases may irritate the gastric lining and should be avoided in patients with active gastritis or ulcer disease.
Stop if no benefit: Lack of improvement after several meals suggests poor mechanistic fit.⁴,⁵
Medical oversight required: Persistent vomiting, inability to tolerate liquids, or worsening abdominal pain warrants clinician evaluation to rule out severe gastroparesis or obstruction.

Final takeaway

Digestive enzymes do not reliably improve sulfur burps, bloating, or fullness caused by GLP-1 medications because they do not correct the underlying problem—delayed gastric emptying. While fermentation may contribute secondarily, enzymes address digestion rather than motility and therefore fail to treat the root cause of symptoms.¹–⁵

Disclaimer

This article is for educational purposes only and is not a substitute for medical advice.

About the Author

Dr. Joshua Silva, MD, is a licensed physician and Medical Director of Potere Health MD. He earned his medical degree from the University of Hawaiʻi John A. Burns School of Medicine and completed residency training in Occupational and Environmental Medicine at the University of Utah, where he also earned a master’s degree in Occupational Health. He later completed a Master of Business Administration with an emphasis in health care administration at Ohio University.

Dr. Silva specializes in evidence-based weight management and routinely manages GLP-1 therapy and medication-related digestive side effects, including bloating, sulfur burps, nausea, and tolerability concerns, for patients at Potere Health MD in St. George, Utah. His physician-led approach emphasizes physiologic mechanisms, safe symptom management, and long-term metabolic outcomes through both in-person and telehealth care across Southern and Northern Utah.

Sources

1. Jalleh RJ, Plummer MP, Marathe CS, et al. Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide. J Clin Endocrinol Metab. 2024;110(1):1-15. https://pubmed.ncbi.nlm.nih.gov/39418085/

2. Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse effects of GLP-1 receptor agonists. Rev Diabet Stud.2014;11(3-4):202-230. https://pmc.ncbi.nlm.nih.gov/articles/PMC5397288/

3. Camilleri M, et al. Effects of GLP-1 and other gut hormone receptors on the gastrointestinal tract and implications in clinical practice. Clin Gastroenterol Hepatol. Published 2024. Accessed January 22, 2026. https://pubmed.ncbi.nlm.nih.gov/37753925/

4. Ianiro G, Pecere S, Giorgio V, et al. Digestive enzyme supplementation in gastrointestinal diseases. Curr Drug Metab. 2016;17(2):187-193. https://pmc.ncbi.nlm.nih.gov/articles/PMC4923703/

5. Graham DY, Ketwaroo GA, Money ME, Opekun AR. Enzyme therapy for postprandial distress. J Dig Dis.2018;19(11):650-656. https://pmc.ncbi.nlm.nih.gov/articles/PMC6910206/

6. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. The effect of oral α-galactosidase on intestinal gas production and gas-related symptoms. Dig Dis Sci. 2007;52:78-83. https://pubmed.ncbi.nlm.nih.gov/17151807/

7. Di Nardo G, Oliva S, Ferrari F, et al. Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo-controlled trial. BMC Gastroenterol. 2013;13:142. https://link.springer.com/article/10.1186/1471-230X-13-142

8. Garvey SM, Guice JL, Hollins MD, Best CH, Tinker KM. Fungal digestive enzymes promote macronutrient hydrolysis in an INFOGEST in-vitro digestion model. Food Chem. 2022;386:132777. https://www.sciencedirect.com/science/article/pii/S0308814622007397

9. König J, Holster S, Bruins MJ, Brummer RJ. Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting. Sci Rep. 2017;7:13100. https://pmc.ncbi.nlm.nih.gov/articles/PMC5638938/

10. Montserrat V, Bruins MJ, Edens L, Koning F. Influence of dietary components on Aspergillus niger protease-mediated protein degradation. Food Chem. 2015;174:440-445. https://pubmed.ncbi.nlm.nih.gov/25529703/

11. Fried M, Abramson S, Meyer JH. Passage of salivary amylase through the stomach in humans. Dig Dis Sci.1987;32:1097-1103. https://link.springer.com/article/10.1007/BF01300195